Clinical Trial
Published on 26 Oct 2020
A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.578756
- 13,552 views
- 50 citations

